Safety and efficacy of sunitinib in metastatic renal cell carcinoma (mRCC): Preliminary assessment of an Italian expanded-access program (EAP) with subpopulation analysis

被引：0
|
作者：
Stemberg, Cora N.
Porta, Camillo
Bracarda, Sergio
Carteni, Giacomo
Lo Re, Giovanni
Ruggeri, Enzo M.
Conte, Pierfranco
Monfardini, Silvio
Gasparini, Giampietro
Ciuffreda, Libero
Marini, Giovanni
Bonetti, Andrea
Heouaine, Abdhelhamid
Bernardini, Ilaria
Ravaioli, Alberto
Labianca, Roberto
机构：
来源：
JOURNAL OF UROLOGY | 2008年 / 179卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：418 / 418
页数：1
相关论文
共 50 条
  • [21] Sunitinib in patients (pts) from Latin America: Final results of the expanded-access trial in metastatic renal cell carcinoma (mRCC)
    Barrios, C. H.
    Herchenhorn, D.
    Chacon, M.
    Cabrera-Galeana, P.
    Monaco, M.
    Sajben, R.
    Zhang, K.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S652 - S652
  • [22] SUNITINIB IN METASTATIC RENAL CELL CARCINOMA (MRCC) PATIENTS (PTS) WITH BRAIN METASTASES (METS): DATA FROM AN EXPANDED-ACCESS STUDY
    Bracarda, S.
    Hariharan, S.
    Szczylik, C.
    Porta, C.
    Hawkins, R.
    Bjarnason, G. A.
    Oudard, S.
    Lee, S. H.
    Carteni, G.
    Gore, M.
    EUROPEAN UROLOGY SUPPLEMENTS, 2009, 8 (04) : 182 - 182
  • [23] Sunitinib in metastatic renal cell carcinoma: An ethnic Asian subpopulation analysis for safety and efficacy
    Lee, Se-Hoon
    Bang, Yung-Jue
    Mainwaring, Paul
    Ng, Christina
    Chang, John W-C
    Kwong, Philip
    Li, Rubi K.
    Sriuranpong, Virote
    Toh, Chee-Keong
    Yuan, Jinyu
    Pitman Lowenthal, Susan
    Chung, Hyun C.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 (03) : 237 - 245
  • [24] A pooled analysis of the efficacy and safety of sunitinib in elderly patients with metastatic renal cell carcinoma (mRCC)
    Hutson, T. E.
    Bukowski, R.
    Rini, B. I.
    Gore, M. E.
    Larkin, J. M.
    Figlin, R. A.
    Barrios, C. H.
    Escudier, B.
    Lin, X.
    Fly, K.
    Martell, B.
    Matczak, E.
    Motzer, R. J.
    BJU INTERNATIONAL, 2012, 109 : 5 - 6
  • [25] Short- and long-term safety with sunitinib in an expanded access trial in metastatic renal cell carcinoma (mRCC)
    Porta, C.
    Szczylik, C.
    Bracarda, S.
    Hawkins, R.
    Bjarnason, G. A.
    Oudard, S.
    Lee, S.
    Carteni, G.
    Hariharan, S.
    Gore, M. E.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [26] Sunitinib in Clinical Practice: the Expanded Access Program for Metastatic Renal Cell Carcinoma
    Marschner, Norbert
    ONKOLOGIE, 2010, 33 : 12 - 14
  • [27] Efficacy and safety data in elderly patients with metastatic renal cell carcinoma included in the nivolumab Expanded Access Program (EAP) in Italy
    Vitale, Maria Giuseppa
    Scagliarini, Sarah
    Galli, Luca
    Pignata, Sandro
    Lo Re, Giovanni
    Berruti, Alfredo
    Defferrari, Carlotta
    Spada, Massimiliano
    Masini, Cristina
    Santini, Daniele
    Ciuffreda, Libero
    Ruggeri, Enzo Maria
    Bengala, Carmelo
    Livi, Lorenzo
    Fagnani, Daniele
    Bonetti, Andrea
    Giustini, Lucio
    Hamzaj, Alketa
    Procopio, Giuseppe
    Caserta, Claudia
    Sabbatini, Roberto
    PLOS ONE, 2018, 13 (07):
  • [28] A pooled analysis of the efficacy and safety of sunitinib in elderly patients (pts) with metastatic renal cell carcinoma (mRCC).
    Hutson, T. E.
    Bukowski, R. M.
    Rini, B. I.
    Gore, M. E.
    Larkin, J. M. G.
    Figlin, R. A.
    Barrios, C. H.
    Escudier, B.
    Lin, X.
    Fly, K. D.
    Martell, B.
    Matczak, E.
    Motzer, R. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [29] Final results from the large sunitinib global expanded-access trial in metastatic renal cell carcinoma
    Gore, M. E.
    Szczylik, C.
    Porta, C.
    Bracarda, S.
    Bjarnason, G. A.
    Oudard, S.
    Lee, S-H
    Haanen, J.
    Castellano, D.
    Vrdoljak, E.
    Schoeffski, P.
    Mainwaring, P.
    Hawkins, R. E.
    Crino, L.
    Kim, T. M.
    Carteni, G.
    Eberhardt, W. E. E.
    Zhang, K.
    Fly, K.
    Matczak, E.
    Lechuga, M. J.
    Hariharan, S.
    Bukowski, R.
    BRITISH JOURNAL OF CANCER, 2015, 113 (01) : 12 - 19
  • [30] Final results from the large sunitinib global expanded-access trial in metastatic renal cell carcinoma
    M E Gore
    C Szczylik
    C Porta
    S Bracarda
    G A Bjarnason
    S Oudard
    S-H Lee
    J Haanen
    D Castellano
    E Vrdoljak
    P Schöffski
    P Mainwaring
    R E Hawkins
    L Crinò
    T M Kim
    G Carteni
    W E E Eberhardt
    K Zhang
    K Fly
    E Matczak
    M J Lechuga
    S Hariharan
    R Bukowski
    British Journal of Cancer, 2015, 113 : 12 - 19
12345